Rangering i aksjer
#21916
ABIONYX Pharma SA is a biotechnology company dedicated to the identification... ABIONYX Pharma SA is a biotechnology company dedicated to the identification and advancement of therapies for conditions affecting the kidneys and eyes. The firm's pipeline includes CER-001, an innovative negatively-charged lipoprotein particle. This compound is designed to mimic the structural and functional attributes of pre-beta HDL, utilizing human recombinant apoA-I (a natural high-density lipoprotein protein) along with natural phospholipids like sphingomyelin and dipalmitoylphosphatidylglycerol. CER-001 is currently under development for patients recovering from acute coronary syndrome and those with familial primary hypoalphalipoproteinemia. Another key candidate, CER-002, is a specific agonist for peroxisome proliferator-activated receptor delta, targeting cardiovascular and metabolic diseases. Additionally, CER-209 is being developed as a potential treatment for metabolic liver diseases, atherosclerosis, and non-alcoholic steatohepatitis (NASH). ABIONYX maintains strategic partnerships with GTP Biologics and VBI Therapeutics Group for the bioproduction of its bio-HDL in France. Established in 2005, the company operated as Cerenis Therapeutics Holding SA before its rebranding to ABIONYX Pharma SA in August 2019. Its operations are headquartered in Balma, France.
Aksjekurs
$2.32
Sist synkronisert: 2026-08-21
Handel ABIONYX Pharma S.A. (ABNX)
Pris ABNX pris med markedsverdi på B
Markedsverdi av ABIONYX Pharma S.A.(ABNX)
Markedsverdi: $98.03M
Per August 2026 har ABIONYX Pharma S.A. en markedsverdi på $98.03M. Dette gjør ABIONYX Pharma S.A. til det 21916th mest verdifulle selskapet i verden basert på markedsverdi ifølge våre data. Markedsverdi er den totale markedsverdien av et børsnotert selskaps utestående aksjer og brukes vanligvis til å måle hvor mye et selskap er verdt.
Markedsverdihistorikk for ABIONYX Pharma S.A. fra 2015 til 2026
ABNX sammenlignet med topp 5 mest populære stocks
| Pris på ABNX |
|
Eiendel B |
Markedsverdi for B |
Resultater |
|
|
|
|
$5.211T
|
+5,316,238.88%
|
|
|
|
|
$4.547T
|
+4,638,228.81%
|
|
|
|
|
$4.162T
|
+4,246,218.63%
|
|
|
|
|
$3.593T
|
+3,665,058.50%
|
|
|
|
|
$2.793T
|
+2,849,009.38%
|
